Influence of exogenous, physiological and factors of chronic inflammatory process on indicators of disturbances of adaptive processes of the person

Irina Sokolovskaya, Irina Kryachok, Inna Chorna, Igor Semeniv, Andriy Kotuza, Nataliia Hryhorieva, Olga Plakhotnik, Valentyna Zarytska, Vladimir Zhuravel, Yaroslav Kmetyuk, Alla Kondratiuk

Abstract

Changes in laboratory parameters can be caused by physical, chemical, biological and other external factors, depending on physiological conditions, in most cases they have an adaptive nature, and it is not always possible to distinguish them from physiological fluctuations. At the same time, obvious shifts in laboratory parameters may indicate a violation of adaptation processes and damage of tissues and organs, despite the absence of clinical manifestations of a disease.

Keywords

platelet aggregation; Willebrand factor; thrombosis; fibrin; hemostasis system; inflammation; exogenous; chemical and physiological factors

Full Text:

PDF

References

Savchenko RP, Gordyushina IV. Effect of oxidative stress on platelet activation in patients with renal pathology; 2004:48-51.

Orosz CG. Endothelial activation and chronic allograft rejection, Clin. Transplant;2014, pp.299-303.Orosz C.G. Endothelial activation and chronic allograft rejection, Clin. Transplant 2014:299-303.

Poller L, Thomson J. The partial thromboplastin (cephalin) time test. Journal of Clinical Pathology 1972;25(12):1038-1044. https://doi.org/10.1136/jcp.25.12.1038

Hattersley P, Hayse D. The Effect of Increased Contact Activation Time on the Activated Partial Thromboplastin Time. American Journal of Clinical Pathology 1976;66(3):479-482. https://doi.org/10.1093/ajcp/66.3.479

NEUBAUER R. Free radicals and antioxidants. The Lancet 1994;344(8934):1440-1442. https://doi.org/10.1016/s0140-6736(94)90612-2

Kattula S, Byrnes J, Wolberg A. Fibrinogen and Fibrin in Hemostasis and Thrombosis. Arteriosclerosis, Thrombosis, and Vascular Biology 2017;37(3):. https://doi.org/10.1161/atvbaha.117.308564

Mavrov GI, Belozerov AP 2003; Rudyk YuS, 2005, pp.16-18.

Smith S, Morrissey J. Polyphosphate enhances fibrin clot structure. Blood 2008;112(7):2810-2816. https://doi.org/10.1182/blood-2008-03-145755

Schmidt K, Noureen A, Kronenberg F, Utermann G. Structure, function, and genetics of lipoprotein (a). Journal of Lipid Research 2016;57(8):1339-1359. https://doi.org/10.1194/jlr.r067314

Ambunin VG, Zakharin AK. Conjugation of changes in catecholamines, thiol compounds and lipid peroxidation in bronchial asthma. 2011, pp.63-66.

Kisiel W, Canfield W, Ericsson L, Davie E. Anticoagulant properties of bovine plasma protein C following activation by thrombin. Biochemistry 1977;16(26):5824-5831. https://doi.org/10.1021/bi00645a029

Nawroth P, Handley D, Esmon C, Stern D. Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity.. Proceedings of the National Academy of Sciences 1986;83(10):3460-3464. https://doi.org/10.1073/pnas.83.10.3460

Moore K, Tabas I. Macrophages in the Pathogenesis of Atherosclerosis. Cell 2011;145(3):341-355. https://doi.org/10.1016/j.cell.2011.04.005

Dandekar A, Mendez R, Zhang K. Cross Talk Between ER Stress, Oxidative Stress, and Inflammation in Health and Disease. Methods in Molecular Biology 2015;:205-214. https://doi.org/10.1007/978-1-4939-2522-3_15

Abu Ebeyn Ahmad Mohamed. Clinico-immunological and pharmacological aspects in the local treatment of chronic prostatitis. Urology; 2003, pp.66-68.

Adaskevich VP. Sexually transmitted diseases. – Vitebsk: edit. Vitebsk medical university; 2014, p.310

Guskov AR, Yacevich GB, Turna AA. Laboratory monitoring of aspirate in transurethral drainage of the prostate gland in patients with chronic obstructive prostatitis, Urology; 2011, pp.15-20.

Visir V, Makurina G. State of free-radical processes and antioxidant defence of patients with psoriasis and concomitant essential hypertension. Zaporozhye Medical Journal 2016;0(4):. https://doi.org/10.14739/2310-1210.2016.4.79730

Brott D, Katein A, Thomas H, Lawton M, Montgomery R, Richardson R, Louden C. Evaluation of von Willebrand Factor and von Willebrand Factor Propeptide in Models of Vascular Endothelial Cell Activation, Perturbation, and/or Injury. Toxicologic Pathology 2014;42(4):672-683. https://doi.org/10.1177/0192623313518664